Previous Close | 6.80 |
Open | 6.82 |
Bid | 6.89 x 1300 |
Ask | 6.90 x 800 |
Day's Range | 6.79 - 7.13 |
52 Week Range | 3.66 - 11.82 |
Volume | |
Avg. Volume | 541,103 |
Market Cap | 236.805M |
Beta (5Y Monthly) | -1.00 |
PE Ratio (TTM) | 5.15 |
EPS (TTM) | 1.36 |
Earnings Date | Aug 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Co-Diagnostics (NASDAQ:CODX) has had a great run on the share market with its stock up by a significant 59% over the...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be attending and speaking at the Yale School of Public Health SalivaDirect™ Conference held July 28-29 in Chicago, Il.
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company's customer and distributor update today at AACC.